Development of vaccines against tuberculosis

被引:16
|
作者
Tyagi, Anil K. [1 ]
Nangpal, Prachi [1 ]
Satchidanandam, Vijaya [2 ]
机构
[1] Univ Delhi S Campus, Dept Biochem, New Delhi 110021, India
[2] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India
关键词
Mycobacteria; Tuberculosis; Vaccines; Immune responses; PLASMA-MEMBRANE PROTEINS; BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-BOVIS BCG; HOST IMMUNE-RESPONSES; REGULATORY T-CELLS; IMMUNODOMINANT ANTIGENS; PROTECTIVE EFFICACY; CROSSED IMMUNOELECTROPHORESIS; SUPEROXIDE-DISMUTASE; 19-KDA LIPOPROTEIN;
D O I
10.1016/j.tube.2011.01.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Development of an effective vaccine against tuberculosis (TB) hinges on an improved understanding of the human immune responses to Mycobacterium tuberculosis. A successful vaccination strategy should be able to stimulate the appropriate arm of the immune system with concomitant generation of the memory cells. In the absence of a perfect strategy, while long term efforts of TB researchers continue to resolve the nature of protective immunity against TB and other related issues, the current approach, dictated by the urgency of a TB vaccine, employs available knowledge and technology to develop new TB vaccines and channel the promising ones to clinical trials. While Indian scientists have contributed in several areas towards the development of a TB vaccine, this review is an attempt to summarize their contributions mainly pertaining to the discovery of new antigens, immune responses elicited by antigens against TB and development of new vaccines and their evaluation in animal models. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:469 / 478
页数:10
相关论文
共 50 条